Introduction
============

In April 2004, the world health organization (WHO) and the world bank released the road traffic report injury prevention, which predicted that by 2020, road traffic injuries will become the third global disease burden, among which fatigue driving is one of the causes ([@b1-etm-0-0-7293]). The direct and indirect total loss and social cost caused by fatigue are extensive ([@b2-etm-0-0-7293]). Currently, there is no convenient fatigue detection method, and several research groups are actively studying occupational fatigue detection. In Western developed countries, we see a substantial investment in this field ([@b3-etm-0-0-7293]). However, the objective data are very difficult to obtain, and the measuring methods and the evaluation indexes are very difficult to quantify ([@b4-etm-0-0-7293],[@b5-etm-0-0-7293]). The sensitivity of existing fatigue detection methods is high; however, it is invasive and the signal paste electrode needs to be extracted.

The percentage of eyelid closure over the pupil over time (PERCLOS) has a high measurement accuracy, and its detection of behavioral characteristics is straightforward. Nevertheless, the detection and identification rules are complex, the pupil measurement information is difficult to extract, and the detection of viewing direction and mouth state is greatly affected by the individual, light and physiological conditions. Additionally, the method has poor reliability and anti-interference performance. Previous findings showed that the microarray technology developed in Japan and the vehicle-mounted module system ([@b6-etm-0-0-7293]) developed in the USA have improved detection efficiency. However, it is difficult for the method to be popularized due to the complex design and high-cost performance ([@b7-etm-0-0-7293],[@b8-etm-0-0-7293]). Recently, Bhatti *et al* ([@b9-etm-0-0-7293],[@b10-etm-0-0-7293]) reported that the level of DNA damage repair in individuals who work at night (work for 8 h at night and change shifts after 6:00 a.m. the next morning) is very low compared with that in individuals who sleep at night. The former is only 20% of the latter. The problem associated with this method is the inconvenience associated with urine sampling and the fact that this method can be affected by renal function and drinking. Thus far, there has been no convenient, reliable, non-invasive and highly cost-effective fatigue detection method, and it is imperative that one or a group of clinical markers be identified. This is the present hotspot and difficulty in research worldwide, as well as a major public health problem faced by developing countries and developed countries ([@b11-etm-0-0-7293]).

The study on fatigue involves the physiology, molecular biomedicine, preventive medicine, computer technology, imaging and other fields. In this study, based on the previous disciplinary studies, the saliva that was clinically collected in a convenient and non-invasive manner was used ([@b8-etm-0-0-7293]--[@b10-etm-0-0-7293]). Compared with the innovated blood detection and urine detection affected by kidney and other factors, the saliva secreted by the glands is more stable and easy to be sampled. The prospect of saliva component analysis used for fatigue detection has attracted much attention in China as well as other countries ([@b12-etm-0-0-7293]). The determination of degree of fatigue via detecting saliva, developed jointly by the University of Toyama and enterprises, is simpler than the method of measuring brain waves. Studies have shown that the salivary gangliosides, cortisol and other small molecules show regular changes in the fatigue state, but it is difficult to establish a convenient detection system. The indices obtained in these studies are usually unstable small molecular substances, which are not conducive to the later promotion and application of fatigue detection ([@b13-etm-0-0-7293]). In this study, the mature saliva time of flight mass spectrometry at present was performed to identify the different high-molecular-weight peptide segments in the fatigue and non-fatigue states to provide an important theoretical basis for the study on more convenient and stable fatigue markers. The type of fatigue investigated in the current study was the fatigue caused by continuous work. After volunteers\' continuous work, fatigue Theta waves were monitored, and the changes of the peptide spectrum was detected in saliva by MALDI-TOF-MS at different time-points. The fatigue wave of ECG was used as the diagnostic criterion to identify fatigue bio-markers. The current study investigated occupational fatigue markers caused by continuous work based on the diagnostic criteria of chronic fatigue syndrome previously described ([@b23-etm-0-0-7293]). Fukuda *et al* ([@b14-etm-0-0-7293]) developed the diagnostic standard of fatigue that was recognized as a golden standard by the international medical community, as well as EEG Theta wave, ECG HF and LF/HF ratio changes.

Materials and methods
=====================

### Inclusion and exclusion criteria

Inclusion criteria were: normal healthy men and women aged 30--45 years, who signed the informed consent, and who were without organic diseases and chronic fatigue symptoms. Exclusion criteria were according to Breithaupt-Groegler *et al* ([@b15-etm-0-0-7293]): i) individuals with persistent or recurrent fatigue for \>6 months; ii) individuals with sore throat; iii) individuals with neck or axillary lymph node swelling and pain; iv) individuals with muscle pain; v) individuals with multiple non-arthritic pain; vi) individuals with headache; vii) individuals with sleep disorders; viii) individuals with discomfort for \>24 h after fatigue; ix) individuals with oral disease; x) individuals not taking drugs and dietary nutritional supplements in the last 3 months, and smokers and those who received tooth filling treatment during the week prior to the sampling date were excluded.

### Participants

Only 10 healthy volunteers (5 males and 5 females) aged 30--45 years were enrolled due to the high experimental cost. The subjects volunteered to participate in this study and signed the informed consent. Saliva samples were collected from April 10, 2015 to April 12, 2015. The present study was approved by the Ethics Committee of Hebei University of Engineering, Affiliated Hospital, College of Medicine (Handan, China) on March 12, 2014, and informed consent was signed (Clinical Trial Registration no.: ChiCTR-DCD-14005746).

Prior to the study, the 10 subjects had good sleep and underwent an electroencephalogram (EEG) while awake. Since there was no fatigue wave, the subjects were considered to have no fatigue or MS/CFS. Subsequently, they began to work continuously to cause fatigue. Physiological responses were also measured using a fatigue scale. At different time-points, the fatigue response gradually increased and the subjects\' saliva was collected. MALDI-TOF-MS peptide peak detection was performed at the end.

### Saliva sample collection

i\) Saliva sample collection: A Saliva collection tube (ISO9001 certified; Cryo.s™; Greiner Bio-One GmbH, Frickenhausen, Germany) was used. The samples were collected by physicians once prior to shifts commencing and once after at least 18 h. Before sampling, the mouth was rinsed three times with distilled water (30 ml NS for 1 min) and subjects sat quietly for 5 min in front of a mirror in an upright sitting position; the head slightly leaned forward and the eyes were kept open for masticatory movement to stimulate the secretion of saliva. When a certain amount of saliva was accumulated in the lower jaw, the tongue reached the upper jaw, the mouth was opened and the tongue was naturally lifted to form a V shape in the lower lips, allowing the saliva to flow into the saliva collection tube prepared in advance. Then 2 ml of saliva was collected and the interval between sampling and eating and the recipe characteristics were recorded. ii) Saliva sample storage: The sample was labeled by the science assistant, and stored at −70°C. iii) Saliva sample detection was conducted by the National Key Laboratory of Institute of Infectious Diseases Prevention and Control of Chinese Center for Disease Control and Prevention (MALDI-TOF MS).

### EEG detection and data collection

The EEG was obtained after at least 18 h to verify the presence of the fatigue wave (the slow wave increased and fast wave decreased; i.e., the quantities of delta, alpha and beta waves were compared). When the fatigue wave appeared, the saliva was immediately collected. EEG was monitored and obtained using the SOLAR-RTA and SOLAR-BFM brain function monitoring system (manufactured by SOLAR Electronic Technology Limited) for real-time analysis and comprehensive analysis of brain function.

### Saliva flight mass spectrometry

Reagents and instruments: WCX magnetic beads kit; α-cyano-4-hydroxycinnamic acid (HCCA) (both from Bruker, Billerica, MA, USA), mass concentration: 0.3 g/l; ethanol (chromatographic grade)/acetone (chromatographic grade) = 2/1, prepared freshly; AutoFlexIII type matrix assisted laser desorption ionization time of flight (MALDI-TOF) mass spectrometer (Bruker). WCX magnetic bead processing: WCX magnetic beads kit was taken from the refrigerator at 4°C and treated according to the protocol. Finally, the eluted peptide sample solution was transferred into a clean 0.5 ml tube for mass spectrometric analysis. For sample application and mass spectrometric analysis, 1 µl peptide sample solution was separated by magnetic beads and 1 µl saliva was taken and dried at room temperature, followed by the addition of 1 µl HCCA matrix solution in the concentration of 3 g/l (dissolved in 50% acetonitrile and 2% trifluoroacetic acid). The prepared sample panels were placed on the MALDI-TOF mass spectrometer for analysis. Under the linear mode, the relative molecular weight between 1,000 and 10,000 Da with a laser energy of 20% was collected for a total of 400 shots. Beads enrichment (MB) saliva and saliva supernatant (stock solution) taken after centrifugation at 12,000 × g for 10 min at 4°C were used for mass spectrometric analysis. A scan was performed 50 times, and the peptide mass fingerprint (PMF) was obtained.

Quality control: Before the test, the relevant group members were trained. Saliva was collected and the fatigue state was maintained. The subjects were informed about the details, and the chest cards were issued to the volunteers. The personnel responsible for saliva collection guidance and supervision were assigned. Each member of saliva sampling needed to accept the strict and unified training. The subjects could collect their own samples, and a specially-assigned person was responsible for EEG and supervision of sleep deprivation.

### Statistical analysis

The molecular weight of collection ranged from 1 and 15,000 Da, and the standard product was selected for molecular weight correction. To establish the model and conduct the blind screening test, the genetic algorithm (GA) model was established and verified using the Clin Pro Tools (version 3.3.0) software provided by Bruker.

Results
=======

### Mass spectrograms of samples

Both MB and direct sampling can detect spectrograms between 1,000 and 15,000 Da ([Fig. 1A](#f1-etm-0-0-7293){ref-type="fig"}), and some peaks which had little effect on the results were lost in the enrichment ([Fig. 1B](#f1-etm-0-0-7293){ref-type="fig"}). The early and late spectrograms of each person were different ([Fig. 1C](#f1-etm-0-0-7293){ref-type="fig"}), and the cross validation was not conducted due to the limited sample size, therefore two spectrograms were taken for each sample. Twenty early and 20 late spectrograms were used for modeling analysis. Three different peptides found in the two groups of stock solution samples have different expression in the fatigue and non-fatigue groups.

With the increase of fatigue, the number of peptides collected in saliva at different time-points increased significantly, especially in the range of high molecular weight (\>5,000 Da). Under the same collecting parameters, when the molecular weight was \>3,000, the peptide abundance in the fatigue population was significantly increased.

### Model identification

The model was established via the mass spectra of MB and supernatant (stock solution) directly collected after centrifugation. A GA model was constructed to distinguish the fatigue and non-fatigue groups. The two parameters of cross-validation and recognition capability were calculated by ClinProTools (Bruker). For the GA typing model, the crossvalidation values, which reflect the model\'s ability to handle variability among test spectra, and the recognition capability value, which reflects the model\'s ability to correctly identify its component spectra, were all 100%. The cross validity of the MB model was 92.06%, while that of the stock solution model was 95.49% ([Table I](#tI-etm-0-0-7293){ref-type="table"}). The strain distribution map based on the GA classification model also showed that the fatigue and non-fatigue groups could be divided into one of two categories based on their PMFs ([Fig. 2](#f2-etm-0-0-7293){ref-type="fig"}).

Discussion
==========

The damage caused by fatigue every year accounts for 21.7% in the global occupational injuries, and 57% of traffic associated deaths can be linked to fatigue ([@b16-etm-0-0-7293]). In China, approximately 600,000 individuals lose their lives annually due to this type of accident ([@b17-etm-0-0-7293]). However, there is no non-invasive and convenient fatigue testing technology, similar to that for detecting drivers\' alcohol level. In the Center for Health Studies of University of Sydney, the EEG signals collected were treated with artificial neural network and it was found that Theta wave was increased significantly under fatigue state, which provided the basis for the detection of fatigue ([@b18-etm-0-0-7293]). EEG is also known as the golden standard for testing fatigue, which can be used as the reference of diagnostic test ([@b19-etm-0-0-7293]). However, the signal must be extracted using the electrode in contact with the human body ([@b20-etm-0-0-7293]). At present, there is no golden standard for the diagnosis of fatigue, and most of the tools for diagnosing fatigue are fatigue scale, such as in literature ([@b21-etm-0-0-7293]--[@b23-etm-0-0-7293]). Fukuda *et al* ([@b14-etm-0-0-7293]) developed the diagnostic standard of fatigue that was recognized as a golden standard by the international medical community, as well as EEG Theta wave, ECG HF and LF/HF ratio changes. The fatigue diagnostic devices in the past were mainly the driving anti-sleep device ([@b24-etm-0-0-7293]), eye movement measurement system ([@b25-etm-0-0-7293]), automobile driver fatigue evaluation method ([@b26-etm-0-0-7293]) and high-speed image processing chip TMS320DM642 fatigue detection and early warning system (TI). The cost associated with these methods is high and its popularity is also limited ([@b27-etm-0-0-7293]). In the present study, the time-of-flight mass spectrometer was used for analysis of saliva samples obtained from a number of individuals under the limited fatigue state. Significant differences were found in the detected spectrograms, and these spectrograms were obtained within 2,000-15,000 Da by the MB and direct sampling. Several differential peptides were found and the saliva peptide mapping showed significant changes with a certain rule with the appearance of fatigue. These results proved the feasibility of fatigue identification via the analysis of saliva marker peptide. The model was established using the mass spectrums of MB and supernatant (stock solution) directly collected after centrifugation. The cross validity of MB model was 92.06%, while that of stock solution model was 95.49%.

In recent years, saliva proteomics research has attracted wide attention ([@b28-etm-0-0-7293]), and 309 different proteins have been identified successfully using the proteomics technique from normal human whole saliva. By dividing the functions of these proteins, proteins with unknown functions account for the most (28.7%), the immune-related proteins account for 21%, whereas proteins with functions linked to replication and repair accounted for 1.6%. In addition, proteins involved in the cell dynamics and those secretion-related account for 4.8%, transcription and ribose-related proteins account for 2.3%, the cell proliferation and cell cycle-related proteins account for 4.2%, signal transduction proteins for 9.7%, metabolism-related protein for 5.2%, and cytoskeleton and intima-related proteins for 7.1% ([@b29-etm-0-0-7293]). The unique and rich proteins in saliva, as a body fluid with a complex ingredient and a variety of biological functions, are undoubtedly the potential source for ideal biomarkers for tumors and other diseases. For a long time, the original technology limited the flux analysis and accurate determination of oral saliva protein; thus, the biological functions of most saliva proteins are unknown, and the potential role of saliva in the diagnosis and prognosis of human diseases is not apparent. With the application of high-throughput and high-precision proteomics, it has been possible to apply biomarkers of saliva proteins in the early diagnosis and prevention of different illnesses, bio-protein-targeted therapy and prognostic monitoring ([@b30-etm-0-0-7293]). This also served as the theoretical basis for selecting saliva in the present study.

Fatigue is a complex biochemical process, and a single biochemical index cannot accurately determine whether the body suffers from fatigue or not. The proteomics study of saliva provides a new direction for the detection of fatigue through saliva. Saliva contains a variety of bioactive ingredients, including some biomarkers that can be used for disease diagnosis ([@b31-etm-0-0-7293]). Compared with blood and urine, the collection process of saliva is simpler and it is completely non-invasive. The role of saliva, instead of blood and urine, in the non-invasive diagnosis of disease, has become increasingly apparent. Studies have shown that small molecules, such as salivary gangliosides (molecular weight: 1,563.85 Da) and cortisol (362.47 Da), are likely to show regular changes under fatigue state, but it is difficult to establish a convenient detection system ([@b32-etm-0-0-7293]). The prospect of saliva component analysis used for fatigue detection has begun to attract much attention in China as well as other countries. Compared with the method that uses brain waves for the determination of fatigue degree, saliva is simpler and less invasive. This method was originally developed by University of Toyama and enterprises.

The mechanism of fatigue is very complex. It has been argued that fatigue was the result of neuro-endocrine-immune network dysfunction caused by a variety of infections and stress, while recent studies have further found that the genetic and metabolic factors may also be involved ([@b33-etm-0-0-7293]). Many studies also investigated the changes in blood chemical composition during the long-term exercise, however the exact pathogenesis is unclear and biomarkers to be used for diagnosis, prevention and treatment has not been found yet. Currently, there is no universally accepted assessment criterion for fatigue. An ideal assessment method for fatigue degree determination can be used for real-time non-invasive assessment with high sensitivity and stability, and can effectively prevent and reduce risks associated with fatigue. Saliva can be obtained in a non-invasive manner. There are several reports on changes in saliva composition ([@b34-etm-0-0-7293]), most of which have been focused on the changes in the levels of metabolic products in the saliva of athletes and soldiers. Besides, the study on fatigue in the medical field is also a marginalized problem ([@b35-etm-0-0-7293]), and the emphasis lies on the analysis of small molecular substances with the molecular weights below 1,000 Da ([@b36-etm-0-0-7293]--[@b39-etm-0-0-7293]). The fatigue-related indexes found in previous studies included cortisol, testosterone and dehydroepiandrosterone ([@b40-etm-0-0-7293]). Indexes obtained in those studies are small and unstable molecules, which were not conducive to the promotion and application of fatigue testing. For example, Kume *et al* ([@b41-etm-0-0-7293]) established the fatigue rat model and found that valine (molecular weight: 117.15 Da), leucine (131.18 Da) and isoleucine (131.17 Da) were significantly increased in the fatigue group compared with those in controlled feeding group, but the levels of citrulline and hydroxyproline were significantly reduced. The level of plasma total nitric oxide in fatigue group was increased, suggesting systemic oxidative stress. In addition, the plasma metabolites in fatigue group were involved in citric acid cycle, such as cis-aconitic acid and isocitrate ([@b42-etm-0-0-7293]). Mathematical model analysis was performed in several studies to screen the different indexes from the healthy control group from dozens of metabolites, such as cis-aconitate, socitrate, citrate and malate ([@b43-etm-0-0-7293]). Michael *et al* ([@b44-etm-0-0-7293]) found through metabolomics analysis that there were metabolites used as the fatigue markers in the saliva of athletes after three-day soccer game, namely 3-methylhistidine (short form: 3M-His), glucose-1-phosphate (short form: G-1-P), glucose 6-phosphate (short form: G-6-P) and some amino acid compound. However, the diagnostic efficacy of these markers was not further analyzed. Recently, Kataoka *et al* ([@b45-etm-0-0-7293]) measured the levels of testosterone (TES), cortisol (CRT) and dehydroepiandrosterone (DHEA) in saliva using the automatic in-tube solid-phase micro-extraction (SPME) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) and found that SPME and LC-MS/MS had a good linear relation (R≥0.9998), precision (intra-day and inter-day precision was 4.9 and 8.5%) and detection sensitivity (limit of quantitation was \~0.01, 0.03 and 0.29 ng/ml saliva) after the treatment of 40 µl samples. Furthermore, this method was also used to analyze the changes in the levels of TES, CRT and DHEA in saliva under pressure and fatigue, showing the advantages of mass-spectrometric technique.

Changes in such small molecules may be associated with fatigue, but these molecules are also susceptible to diets and other health conditions. At the same time, these small molecule markers often lack good antigenicity, and are not easy to detect using the simple methods, such as immunology or biosensor. In this study, the time-of-flight mass spectrometer was used and the results showed that there were significant differences in the spectrograms obtained by the MB and direct sampling within 2,000-15,000 Da. Several differential peptides were detected between groups and the saliva peptide mapping showed significant changes. These results proved the feasibility of fatigue identification via the analysis of saliva marker peptide. The molecular weight range of the markers obtained in this study laid a good foundation for finding the large molecular weight proteome in the later stage. Moreover, the large molecular weight indexes are stable, providing a theoretical basis for finding the fatigue detection indexes similar to the markers used in alcohol detection.

According to the 'Nihon Keizai Shimbun' ([@b46-etm-0-0-7293]), the number of special glucocorticoids in blood may increase during the fatigue, and saliva will secrete α-amylase. The so-called 'heart instrument' is equipped with a chip: The human saliva is placed on the chip, and then the chip is pasted to the instrument to detect the degree of fatigue. The saliva samples of Wiewelhove *et al* ([@b47-etm-0-0-7293]) were obtained from 9 cyclists who participated in a cross-study study aiming at simulating the long-term manual labor, military action and fire rescue during the rest period. The results of this study showed that the distribution difference in fatigue biomarker index (FBI) of subjects was decreased with the increase of the time of physical activity. The self-reported fatigue degree had a significantly positive correlation with the participants\' CFS and serum leptin (16,000 Da) in healthy control, supporting our main hypothesis. The machine learning algorithm can distinguish the 78.3% low fatigue days in the high CFS group ([@b48-etm-0-0-7293]). Related studies found through the conventional evaluation of fatigue and recovery during the high-intensity interval training that creatine kinase (42,000 Da) had statistically significant difference during the fatigue and rest periods ([@b47-etm-0-0-7293]). The above research confirmed the correctness of results in this study indirectly.

Due to the high cost of this study, the sample size was not large. After receiving fund support, we aim to expand the sample size and carry out further study in different groups of individuals.

We concluded that there were different peaks within the molecular weight of 2,000-15,000 Da, which laid a good foundation for the later study on proteomics-based fatigue markers. The idea of fatigue-related biomarkers within 2,000-15,000 Da in this study was also characterized by the stable composition under test, less interference factors *in vivo* and easy conversion and popularization of the detection system. The exploration of fatigue-related biomarkers has theoretical significance and application prospects. In the future, the fatigue queue will be built to find the stable and specific biomarkers and its combinations under the fatigue state and establish the fatigue-related biomarker evaluation model using the mature mass spectrometry high-throughput sample analysis technique. Compared with the previous studies on saliva metabolomics, proteomics results are more stable. In further research, it is expected to systematically establish the saliva identification spectrum that can be used for fatigue identification, so as to provide a scientific basis for the further realization of convenient fatigue detection methods based on the biosensor technique, which has both important theoretical and practical significance.
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Basic information, cross validity (%) and acceptability (%) of the two models.

  Model name       Algorithm   Cross validation   Recognition capability
  ---------------- ----------- ------------------ ------------------------
  MB               GA          92.06%             100%
  Stock solution   GA          95.49%             100%

MB, beads enrichment; GA, genetic algorithm.
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